← Back to All Filings

Guardant Health Director Sells $143K in Stock Post-Option Exercise

Low SignificanceNovember 10, 2025 at 7:32:20 PM EST

Guardant Health, Inc.

$GH4CIK: 0001576280

Subscribe to track GH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Guardant Health Director Sells $143K in Stock Post-Option Exercise

Company: Guardant Health, Inc. (GH) Form: 4 | Filed: 2025-11-10 Significance: Low

Insider: Hidalgo Medina Manuel Title: null | Relationship: Director

Transaction: • Type: Exercise & Sell • Shares Sold: 1,500 • Avg. Price: $95.19 • Value: $142,780 • Owned After: 815

Key Insight: A director exercised options and immediately sold shares, a common practice for realizing gains and covering costs. The transaction value is negligible compared to Guardant Health's $12.19B market cap.

Market Context: This is a routine insider transaction with minimal market impact, representing less than 0.002% of shares outstanding.

Comprehensive Analysis

SEC Filing Analysis: Guardant Health, Inc. (GH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director conducted a routine "exercise-and-sell" transaction, acquiring 1,000 shares via options and subsequently selling a total of 1,500 shares for proceeds of approximately $143k.
  • Market Impact: The transaction is immaterial to the company, representing a negligible fraction of its market capitalization and public float.

Company Information

FieldValue
CompanyGuardant Health, Inc.
Ticker SymbolGH
CIK0001576280
IndustrySERVICES-MEDICAL LABORATORIES

Insider Information

FieldValue
NameHidalgo Medina Manuel
CIK0001865525
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-07
Transaction CodeM, S
Security TypeCommon Stock
Shares Involved1,000 acquired (exercise), 1,500 sold
Price Per Share$32.55 (exercise), ~$95.19 (avg. sale)
Total Value$142,780.15 (total sale value)
Shares Owned After815
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$142,780.15 (Sale)
% of Market Cap0.0012%
Shares Transacted1,500 (Sale)
% of Shares Outstanding0.0012%
Post-Transaction Ownership815 shares (0.00065% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The sale of $143k is insignificant for a company with a market capitalization of $12.19 billion.
  • Ownership Concentration: The director's post-transaction holding of 815 shares is a very small stake in the company.
  • Transaction Significance: The transaction is a common cashless exercise, where an insider sells newly acquired shares to cover the exercise price and taxes, while also realizing a profit. While the sale represented a large portion of the insider's holdings at the time (~65% of shares held post-exercise), its impact on the overall market is negligible due to the small absolute size.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small to influence the stock price. It is a routine personal liquidity event for the insider, not a signal about the company's future prospects.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction size is a tiny fraction of typical daily trading volume.
  • Sentiment Indicator: Neutral. The market will likely view this as a non-event.

Additional Context

Transaction Notes

  • Special Circumstances: The filing details a multi-step transaction: exercising an option to buy 1,000 shares at $32.55 and then selling 1,500 shares at market prices around $95.19. This is a standard way for insiders to monetize vested options.
Topics:#SECFiling#InsiderTrading#GuardantHealth#GH#Form4#InsiderSell#StockMarket#MarketAnalysis#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.